Dominant and Non-Dominant Hands Showed Different Cannabis Pegboard Findings

A cannabis trial in spinal-cord-related neuropathic pain found a motor-performance difference for the non-dominant hand without the same dominant-hand result. Combining the hands into a general statement would lose the measured pattern.

The review separated the two tests

Eadie and colleagues describe Grooved Pegboard testing of dominant and non-dominant hands in a vaporized-cannabis trial. The task assesses manual dexterity and fine motor control. These were clinical human participants with disease or injury affecting the spinal cord.

The affected comparison was specific

The review reports no significant dose-effect differences on the dominant-hand test. The higher-THC condition performed worse than placebo on the non-dominant-hand measure after the second dosing session, with the difference no longer observed at a later assessment. The result should preserve hand, dose and time rather than becoming uniform motor impairment.

A selective null is not proof of full functional recovery

The dominant-hand result does not validate every activity requiring coordination, and the non-dominant finding does not prove that both hands were equally affected. Physical disability can also complicate task completion in this population. The appropriate inference is about the actual comparison, not a universal ability or inability to operate a vehicle. A useful opinion identifies the limb and task relevant to the disputed function before borrowing a general motor label.

Related analysis: the review’s broader findings and limitations.

Research cited

This analysis draws on the supplied review: Eadie and colleagues (2021). Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review. Frontiers in Psychiatry.

Study discussed in that review: DOI 10.1016/j.jpain.2016.05.010.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

A mouse cerebral-malaria experiment summarized in the CBD brain review reported memory findings when CBD was added to artesunate. The observation concerned adjunctive treatment in an infectious-disease model, rather than CBD alone as a general memory enhancer. The disease and co-treatment belonged in the result The review describes CBD treatment…

Spread the love

Read Article: CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Rat experiments summarized in the CBD brain review found different degrees of interference with CBD-related pain responses after serotonin-receptor blockade. The evidence did not establish one exclusive mechanism for every model. The diabetic and nerve-injury models differed In male diabetic rats, the review reports attenuation of mechanical allodynia with CBD…

Spread the love

Read Article: Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

An observational CBD study summarized in the brain-function review reported improvement in pain patients but had substantial participant loss and incomplete dosing information. Those limitations constrained attribution of the change to CBD. The clinical groups did not report one uniform response The review describes Gulbransen and colleagues’ exploratory quality-of-life study….

Spread the love

Read Article: Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us